A Comprehensive Guide to Tagrix 80mg: Benefits & Side Effects
Tagrix 80mg (Osimertinib) is an oral, targeted therapy drug that is prescribed for the treatment of non-small cell lung cancer (NSCLC) patients with a specific genetic mutation called Epidermal Growth Factor Receptor (EGFR) T790M mutation. Tagrix is a third-generation EGFR tyrosine kinase
